Company news

Conneqt Health Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

CardieX and inHealth Collaboration in Landmark US Study

April 2, 2019

CardieX Corporate Update and Report from CEO

March 31, 2019

CardieX Announces Expansion of Bayer Pharma Trial Contract

March 6, 2019

Appendix 4D Half Year Report

February 28, 2019

CardieX Update on the Acquisition of 50.5% of inHealth

February 1, 2019

Convertible Note Application Received from C2 Ventures

January 22, 2019

Response to ASX Aware Query

January 17, 2019

Cardiexs inHealth Executes Major Co-Marketing Agreement

January 14, 2019

CardieXs inHealth Signs LOI With Global Electronics Company

December 17, 2018

CardieX Signs Agreement for Wearable Sensor Development

December 11, 2018

CardieX Successfully Closes Oversubscribed $5.5m Fundraising

December 5, 2018

CEO Strategy Overview and 2019 Plan

December 2, 2018

CardieX Owned inHealth Partners with Kaiser Permanente

November 28, 2018

CardieX Corporate Update & Overview of inHealth Transaction

November 11, 2018

CardieX Partner Blumio Initiates Large Scale Clinical Trial

October 31, 2018

New Medical Devices Supply Contract with AstraZeneca

October 26, 2018

CardieX Subsidiary Wins New Medical Devices Supply Contract

October 25, 2018

Acquisition of Major Stake in inHealth Medical

October 15, 2018

Receipt of Subscription Proceeds from C2 Ventures Pty Ltd

October 11, 2018

CardieX Appendix 4E and 2018 Annual Financial Statements

August 31, 2018

CardieX Reports Successful Trial Results for Wearable Sensor

July 24, 2018

CardieX Makes First Investment in Wearable Tech Partnership

June 18, 2018

CardieX (AtCor) Entitlements Issue Heavily Over Subscribed

June 12, 2018

AtCor Announces Wearable Trial with Macquarie University

May 21, 2018

Blumio Wearable Cardio Trial with Macquarie University

May 20, 2018

Underwritten Rights Issue Prospectus Lodged with ASIC

April 23, 2018

Oversubscribed Capital Raising to Fast Track New Strategy

April 22, 2018

AtCor Announces First Steps in Major Strategic Repositioning

March 14, 2018

AtCors XCEL device clinically validated in 3rd party study

January 23, 2018

AtCor and PhysioAge Systems announce supply agreement

January 10, 2018

AtCor secures $1.0 million new pharmaceutical trial contract

December 14, 2017

AtCor appoints Craig Cooper as CEO

November 30, 2017

Chairmans address to 2017 AGM

November 29, 2017

Tax Refund

October 30, 2017

Security Purchase Plan

September 7, 2017

Full Year Statutory Accounts

August 31, 2017

Share Purchase Plan

August 29, 2017

Share Placement

August 8, 2017

AtCor restructures operations

August 2, 2017

AtCor Signs New Agreement

July 31, 2017

Secures $0.8 million new pharmaceutical trials contracts

July 12, 2017

AtCor Signs New Network Health Systems Agreement

June 6, 2017

Business update and Strategic Review

May 18, 2017

AtCor Signs Local Health System Agreement

February 23, 2017

Study Finds Central Aortic Waveform Improves HF Treatment

February 15, 2017

Tax refund

February 13, 2017

Positive Novartis drug trial using SphygmoCor XCEL

January 22, 2017

AtCor completes share placement

November 15, 2016

Leading research team highlights role of SphygmoCor

November 4, 2016

FY2016 results

August 29, 2016

← Newer news releases · Older news releases →

Decks

The 5 newest of 9 decks. Every deck is listed under its year.